Colossal Biosciences
Advanced genetic engineering and de-extinction research using CRISPR and reproductive technologies to functionally revive extinct species and support conservation
Funding
$555.00M
2025
Details
Headquarters
Dallas, United States
CEO
Ben Lamm
Website
Milestones
FOUNDING YEAR
2021
Listed In
News
The latest coverage and announcements from Colossal Biosciences.